OncoMatch/Clinical Trials/NCT07662629
Addtional Effect of Hyperbaric Oxygen to Programmed Physical Activity on Musckoloskeletal Pain in Breast Cancer Elderly
Official title: Addtion of Hyperbaric Oxygen to Programmed Physical Activity in Aromatse Inhibtors-linked Musckoloskeletal Pain in Breast Cancer Patients
Is NCT07662629 recruiting? Yes, currently enrolling (Oct 2026). This NA trial studies non-drug interventions for breast cancer.
patienst who survived from breast cancer are prescribed long administraion of aromatase inhbitors.. these inhibitors usually induce musckloskeletal pains. Programmed phsyical activity are reommended to improve these pains but effects of HYperbaric oxygen on these pain was not investigated
Check if I qualifyExtracted eligibility criteria
Cancer type
Breast Carcinoma
Demographics
Prior therapy
Must have received: aromatase inhibitor
patients receiving aramatase inhibitor drugs
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07662629 currently recruiting?
Yes, this trial is currently recruiting patients.
Is prior treatment required for enrollment?
Yes. Patients must have previously received aromatase inhibitor.
Is there an age limit?
Yes. Patients must be 75 years or younger and at least 65 years old.
Is this trial open to male patients?
No. This trial enrolls female patients only.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages